Latest Insider Transactions at Neuroone Medical Technologies Corp (NMTC)
This section provides a real-time view of insider transactions for Neuroone Medical Technologies Corp (NMTC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROONE MEDICAL TECHNOLOGIES Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROONE MEDICAL TECHNOLOGIES Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2022
|
Steve Mertens Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,750
+50.0%
|
-
|
|
Feb 03
2022
|
David A Rosa CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+32.7%
|
-
|
|
Feb 03
2022
|
Ronald W. Mc Clurg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 24
2021
|
Mark Christianson Business Development Director |
SELL
Open market or private sale
|
Direct |
600
-0.06%
|
$3,600
$6.3 P/Share
|
|
Jun 23
2021
|
Mark Christianson Business Development Director |
SELL
Open market or private sale
|
Direct |
11,300
-1.04%
|
$67,800
$6.74 P/Share
|
|
Jun 02
2021
|
Edward Andrle Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,592
+24.17%
|
-
|
|
Jun 02
2021
|
Paul Buckman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,592
+12.75%
|
-
|
|
Jun 02
2021
|
Jeffrey S Mathiesen |
BUY
Grant, award, or other acquisition
|
Direct |
4,592
+11.09%
|
-
|